Dopamine and extrapyramidal motor function and dysfunction.
D000818:Animals; D001058:Apomorphine; D001480:Basal Ganglia Diseases / Q000503:physiopathology; D002090:Butyrophenones; D002421:Caudate Nucleus / Q000378:metabolism; D004295:Dihydroxyphenylalanine; D004298:Dopamine / Q000378:metabolism / Q000494:pharmacology / Q000502:physiology*; D004558:Electric Stimulation; D005116:Extrapyramidal Tracts / Q000378:metabolism / Q000502:physiology* / Q000503:physiopathology; D006801:Humans; D010300:Parkinson Disease / Q000503:physiopathology; D010302:Parkinson Disease, Secondary / Q000139:chemically induced; D010640:Phenothiazines; D010648:Phenylacetates / Q000378:metabolism; D012110:Reserpine; D013378:Substantia Nigra / Q000378:metabolism; D014793:Visual Cortex / Q000187:drug effects / Q000378:metabolism
D002090:Butyrophenones; D010640:Phenothiazines; D010648:Phenylacetates; D004295:Dihydroxyphenylalanine; D012110:Reserpine; D001058:Apomorphine; D004298:Dopamine